New Path Molecular Research Ltd
09412383
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/05/2025
micro entity
Next accounts due
28/02/2027
Confirmation statement
Last: 29/01/2026
Due 12/02/2027
Industry
Officers
director · Since 07/05/2015
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 61
Also on 14 other boards
director · Since 07/05/2015
SCIENTIST
BRITISH · UNITED KINGDOM · Age 55
Also on 1 other board
director · Since 15/05/2017
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 74
Also on 1 other board
Persons with Significant Control
Professor Steven Victor Ley
British · England · Age 80
Building 580, Babraham Research Campus, Cambridge, CB22 3AT
Notified 06/04/2016
CompanyRankvs 393+ SIC 72190 peers82
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2025
Net Worth
£254k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£272k
Working capital
Current Assets
£286k
Current Liabilities
£84k
Fixed Assets
£8k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 3.40 | -£27k |
| 2024 | 2.72 | +£168k |
| 2023 | 2.60 | -£163k |
| 2022 | 5.00 | -£114k |
| 2021 | 8.85 | +£160k |
| 2020 | 5.84 | — |
Derived from filed accounts. Not audited figures.